The U.S. Food and Drug Administration (FDA) approved the first blood test to detect Alzheimer's disease in what federal officials called an "important step" toward diagnosing and treating the ...

Biogen BIIB announced that the FDA has granted fast track designation to its investigational Alzheimer's disease (AD) drug, BIIB080. How Does the Fast Track Tag Benefit BIIB’s Drug Development?

A Malvern company has received FDA clearance for a first-of-its-kind blood test to help diagnose Alzheimer's disease. Health experts say the test could revolutionize the diagnosis and care of ...

The U.S. Food and Drug Administration (FDA) has granted approval for a first-of-its-kind blood test to help diagnose Alzheimer’s disease, which could help people begin treatment in the early ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and beta-amyloid 1-42 in plasma.

Biogen has won a U.S. Food and Drug Administration fast-track designation for its investigational BIIB080 therapy for the treatment of Alzheimer's disease. Biogen on Wednesday said BIIB080 is the ...

The FDA's sign-off on marketing for Fujirebio's test comes years after other blood tests for Alzheimer's have already begun sales, without this kind of approval from the agency.

It's paving the way for new and more exciting treatments to come."The clinic's first patient to use the drug was Karen Heathcock of Lincoln."This is the best thing that's happened to me," she said ...

Biogen BIIB announced that the FDA has granted fast track designation to its investigational Alzheimer's disease (AD) drug, BIIB080. How Does the Fast Track Tag Benefit BIIB’s Drug Development ...

Biogen has won a U.S. Food and Drug Administration fast-track designation for its investigational BIIB080 therapy for the treatment of Alzheimer's disease. Biogen on Wednesday said BIIB080 is the ...